Mehdi Hatamian, 2Pi-Sigma - Next-Gen Cancer Screening Technology | LSI USA '25

2Pi-Sigma Corp is developing a revolutionary, low-cost ($50/test), rapid, at-home cancer screening test for early detection.

LSI Asia ‘25 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

June 10th - 13th, 2025The Ritz-Carlton, Millenia Singapore Register arrow